Nukkleus Statistics
Total Valuation
Nukkleus has a market cap or net worth of $87.40 million. The enterprise value is $88.13 million.
Important Dates
The next estimated earnings date is Friday, November 14, 2025, after market close.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nukkleus has 13.55 million shares outstanding. The number of shares has increased by 215.15% in one year.
| Current Share Class | 13.55M |
| Shares Outstanding | 13.55M |
| Shares Change (YoY) | +215.15% |
| Shares Change (QoQ) | -0.84% |
| Owned by Insiders (%) | 25.93% |
| Owned by Institutions (%) | 2.17% |
| Float | 10.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 32.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$35.54M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +184.14% in the last 52 weeks. The beta is -6.29, so Nukkleus's price volatility has been lower than the market average.
| Beta (5Y) | -6.29 |
| 52-Week Price Change | +184.14% |
| 50-Day Moving Average | 6.96 |
| 200-Day Moving Average | 11.88 |
| Relative Strength Index (RSI) | 41.93 |
| Average Volume (20 Days) | 2,035,782 |
Short Selling Information
The latest short interest is 1.36 million, so 10.07% of the outstanding shares have been sold short.
| Short Interest | 1.36M |
| Short Previous Month | 1.63M |
| Short % of Shares Out | 10.07% |
| Short % of Float | 13.60% |
| Short Ratio (days to cover) | 0.38 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.54M |
| Pretax Income | -532.79M |
| Net Income | -533.13M |
| EBITDA | n/a |
| EBIT | -17.54M |
| Earnings Per Share (EPS) | -$110.51 |
Full Income StatementBalance Sheet
The company has $1.52 million in cash and $2.25 million in debt, giving a net cash position of -$727,569 or -$0.05 per share.
| Cash & Cash Equivalents | 1.52M |
| Total Debt | 2.25M |
| Net Cash | -727,569 |
| Net Cash Per Share | -$0.05 |
| Equity (Book Value) | -53.38M |
| Book Value Per Share | -9.94 |
| Working Capital | -53.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.23 million and capital expenditures -$14,847, giving a free cash flow of -$2.25 million.
| Operating Cash Flow | -2.23M |
| Capital Expenditures | -14,847 |
| Free Cash Flow | -2.25M |
| FCF Per Share | -$0.17 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
